Menarini Makes Big US Oncology Move with Stemline Acquisition
Menarini Group, the largest Italian pharmaceutical company by turnover, has made its first move into the US oncology market through the acquisition of…
Tagged with Oncology
Putting People Ahead of the Maths: Addressing the Limitations of…
Mike Glover, Vice President Global Head of Access and Pricing Strategy Oncology at GSK outlines that while new mathematical approaches to health…
Oncology in Morocco: Access Challenges & New Solutions
Morocco has made admirable progress in building a national oncology network in recent years, but the country’s cancer patients still face…
Xu Ting – Founder, Chairman & CEO, Alphamab Oncology,…
PharmaBoardroom caught up with Alphamab Oncology’s founder, chairman and CEO Dr Xu Ting again 16 months after our last interview to hear about their…
Sylvie Rottey – President, Belgian Society of Medical…
Professor Sylvie Rottey, president of the Belgian Society of Medical Oncology (BSMO) outlines the state of cancer care in Belgium, the country’s…
Novartis: CAR-T’s Journey to Market in Europe
Two years on from the introduction of Novartis Oncology’s CAR-T therapy to Europe, Emnuele Ostuni, the firm’s European head of cell and gene…
Emanuele Ostuni – Head of Europe, Cell & Gene Therapy,…
Emanuele Ostuni, Novartis Oncology’s head of cell and gene therapy for Europe, gives an overview of the introduction of the company’s CAR-T…
Pharma Faces: Sandra Sanchez-Oldenhage, GM NoLA Region, Novartis…
Sandra Sanchez-Oldenhage has headed up the North Latin America (NoLA) region for Novartis Oncology since January 2020. In a recent wide-ranging…
Pierre Behnam – General Manager, Pierre Fabre Morocco
Pierre Behnam, general manager of Pierre Fabre in Morocco, breaks down the strong and long-standing footprint of the group in the country in the…
Sandra Sanchez-Oldenhage – General Manager NoLA Region,…
Sandra Sanchez-Oldenhage, General Manager Novartis Oncology North Latin America (NoLa) Region, outlines her concerns regarding access to innovation in…
Eric Halioua – President & CEO, PDC*Line Pharma,…
PDC*Line Pharma’s Eric Halioua introduces the Belgian immuno-oncology biotech, its clinical-stage assets, the impact of the firm’s collaboration…
Daniel Bran – General Manager, Accord Romania
Daniel Bran, GM of Accord Romania reveals that finding the right talent has been one of the most challenging and rewarding milestones in building the…
